Eli Lilly (NYSE:LLY) said today that it pledged up to $52 million to Purdue University as part of a 5-year research agreement. The deal is Purdue’s largest strategic collaboration with a single company, according to the university. The group is slated to focus on improving the delivery of injectable medications with the goals of reducing pain and the […]
Funding Roundup
Dune Medical raises $12m to expand MarginProbe footprint
Dune Medical Devices said today that it raised another $12 million it plans to use to expand the indications for the radiofrequency spectroscopy technology used in its MarginProbe cancer detection device. Alpharetta, Ga.- and Caesarea, Israel-based Dune said the $12.3 million round was led by Canepa Healthcare, ATON Partners and the Kraft Group. Dune said it plans […]
Axonics adds $21m to Series C round
Axonics Modulation Technologies said today that it put another $21 million in its coffers in the second tranche of a Series C round for its sacral nerve modulation technology in treating overactive bladder syndrome. The first, $15 million Series C tranche closed in May. The latest, $20.5 million tranche takes Axonics’ total raise to at least $106.1 […]
Diasome lands $30m to fund clinical trials of liver-targeted insulin
Diasome Pharmaceuticals said today that it inked a funding deal that could bring the company up to $30 million. The round was led by Medicxi and contributed to by JDRF T1D Fund, Black Beret Life Sciences and McDonald Partners. The Cleveland-based company said it plans to use the funds to support the clinical development of […]
Northwestern, University of Calgary win $3m grant for cardiac valve imaging project
Patients who are born with a bicuspid aortic valve have 2 flaps in their cardiac valve instead of 3 – and researchers from Northwestern University and the University of Calgary are planning a 5-year study to evaluate an imaging approach for preventing the complications of this genetic condition. With a $3.3 million grant from the […]
LipoSeuticals closes Series A for novel drug delivery tech
LipoSeuticals said today that it closed a financing round for an undisclosed amount led by Hong Kong-based life sciences fund, Delos Capital. The company has developed a sugar-lipid polymer-based formulation, Sulocence, which boosts drug stability and solubility. LipoSeuticals said it is applying the drug delivery technology to the reformulation of an array of marketed specialty drugs. […]
Titan Medical closes $6m offering
Titan Medical (TSX:TMD) said today that it raised nearly $6 million in a public offering, with company insiders putting up another $166,000. Toronto-based Titan, which is developing the Sport robot-assisted surgery platform, had said it might float up to 100 million shares, which would have fetched $11.5 million. In the event the company floated nearly 48.4 million shares […]
Synspira raises $8m for inhaled pulmonary therapies
Privately-held Synspira said today that raised $8 million from an unnamed private investor to bring its inhaled cystic fibrosis therapy into a Phase I safety study. The Boston-based company was founded earlier this year and is focused on developing inhaled therapies for pulmonary diseases, including cystic fibrosis, chronic obstructive pulmonary disease and pneumonia. Synspira holds an exclusive […]
Bonesupport closes $57m IPO
BoneSupport said last week it closed its initial public offering, raising a total of approximately $57.1 million (SEK 500 million), not including an over-allotment option. The Swedish company, which is developing the Cerament G injectable antibiotic-eluting bone graft substitute, said it floated approximately 17.2 million new shares at $3.40 per share (SEK 29) in the […]
MetaStat lands $7m for personalized cancer diagnostic, therapy tech
MetaStat (OTC:MTST) said this week that it closed the 1st tranche of a $7 million private placement. The round, which was led by Perceptive Advisors, is slated to bring in approximately $2.1 million, according to the Boston-based company. Get the full story at our sister site, Drug Delivery Business News.
Mersana Therapeutics prices $75m IPO
Cambridge-based startup Mersana Therapeutics said today that it raised $75 million in an initial public offering. The company sold 5 million shares of common stock at $15 apiece. Mersana, which debuted on the Nasdaq exchange listed under “MRSN”, also gave underwriters a 30-day option to buy up to 750,000 more shares at $15 per share. […]